Epidermal Growth Factor Receptor Mutation Is Associated With Longer Local Control After Definitive Chemoradiotherapy in Patients With Stage III Nonsquamous Non–Small-Cell Lung CancerShigehiro Yagishita, Tomohide Tamura, Minako Sumi et al.|International Journal of Radiation Oncology*Biology*Physics|2014Cited by 63
Impact of <i><scp>KRAS</scp></i> mutation on response and outcome of patients with stage <scp>III</scp> non‐squamous non‐small cell lung cancerShigehiro Yagishita, Yuichiro Ohe, Hidehito Horinouchi et al.|Cancer Science|2015Cited by 23
Secondary Osteosarcoma Developing 10 Years after Chemoradiotherapy for Non-small-cell Lung CancerShigehiro Yagishita, T Tamura, Hidehito Horinouchi et al.|Japanese Journal of Clinical Oncology|2013Cited by 2
Impact of Kras Mutation on the Response and Prognosis of Patients with Stage III Non-Squamous Non-Small Cell Lung CancerShigehiro Yagishita, T. Tamura, Hidehito Horinouchi et al.|Annals of Oncology|2014Cited by 0
Impact of the presence of EGFR mutation on definitive chemoradiotherapy in patients with locally advanced non-small cell lung cancer: Pattern of relapses and survival analyses in 145 patients.Shigehiro Yagishita, Tomohide Tamura, Hidehito Horinouchi et al.|Journal of Clinical Oncology|2013Cited by 0